All lobbying filings
LMH STRATEGIC SOLUTIONS
LMH STRATEGIC SOLUTIONS filed a Q1 report for BICYCLE THERAPEUTICS on April 20, 2026, reporting $150,000 in lobbying income.
Lobbying for BICYCLE THERAPEUTICS · A clinical-stage biopharmaceutical company.
Filing · LD-2 quarterly report
Q1 report
Reporting period
1st Quarter 2026
Jan 1 - Mar 31 · Posted Apr 20, 2026
Income
$150,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
2
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
-
SOPHIE KHANAHMADIPreviously held: Legislative Asst., Rep. Martha Roby; Legislative Asst., Rep. Lee Terry; Staff Asst./LC, Senator Jeff Sessions
Government bodies contacted
4
Lobbying activity
2
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs.
Healthcare-related legislative and regulatory issues impacting the biotechnology, pharmaceutical, and consumer health industry. General health care coverage and reimbursement for prescription drugs. Drug pricing reform. Food and Drug Administration legislative and regulatory issues.